INDIAN PHARMACEUTICAL INDUSTRY-A PLETHORA OF SUSTAINABLE GROWTH OPPORTUNITIES FOR PHARMA BUSINESS ASPIRANTS
{ DOWNLOAD AS PDF }
ABOUT AUTHORS:
Rhit Srivastava*, Saurabh Kumar Banerjee
School of pharmaceutical management,
The IIHMR University, Jaipur,
Rajasthan, India
rhitsrivastava@gmail.com
INTRODCUTION
Worldwide the Pharmaceutical industry dynamics is undergoing a significant transformation in terms of cutting edge advancement in the areas of pharmaceutical R&D specially the biotechnology based products, innovative drug delivery technologies, and large scale efficient pharmaceutical manufacturing capacities and so on. According to the list published by FDA for GMP facilities producing generic drug products and APIs for the US market 70% of the APIs and FDFs (Finished dosage Form Facilities) are produced outside US and India counts for 23.7 % of the API and FDF facilities and is by far the largest country exporting to the US. Even China counts for less than a half of the FDF and API facilities exporting to the US, as compared to India[1]

